This session will focus on the management of non-alcoholic fatty liver disease (NAFLD) with a particular emphasis on the role of GLP-1 agonists and SGLT-2 inhibitors in treating this condition. The presentation will also review the epidemiology of non-alcoholic fatty liver disease and the initial steps in the evaluation and risk stratification of NAFLD patients presenting in a primary care setting. CME/CE Expiration Date: 4/23/26 *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
- Provider:Obesity Medicine Association
- Activity Link: https://academy.obesitymedicine.org/node/1463
- Start Date: 2023-05-07 05:00:00
- End Date: 2023-05-07 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest